Answers are grounded in this paper and cite their sources.
The use of intramedullary devices to treat osteomyelitis has been documented as being effective and safe. Technology has limited the use of this technique to long bones with application on an intramedullary nail or rod. In this paper, we describe a novel technique using antibiotic synthetic bone void filler (ASBVF) applied into the medullary canal of a transmetatarsal amputation. This backfills a necrotic void and creates a bioabsorbable, antibiotic impregnated filler to resist and treat further advancement or recurrence of osteomyelitis after resection.
No takes yet. Share an insight, caveat, or question.
Poynter et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: